TPA023 metabolite M5(474319-48-7)
- Name: TPA023 metabolite M5
- Synonyms:TPA023 metabolite M5;02X1GF8X88;474319-48-7;UNII-02X1GF8X88;1,2,4-TRIAZOLO(4,3-B)PYRIDAZINIUM, 7-(1,1-DIMETHYLETHYL)-6-((1-ETHYL-1H-1,2,4-TRIAZOL-5-YL)METHOXY)-3-(2-FLUOROPHENYL)-1-.BETA.-D-GLUCOPYRANURONOSYL-;1,2,4-TRIAZOLO(4,3-B)PYRIDAZINIUM, 7-(1,1-DIMETHYLETHYL)-6-((1-ETHYL-1H-1,2,4-TRIAZOL-5-YL)METHOXY)-3-(2-FLUOROPHENYL)-1-.BETA.-D-GLUCOPYRANURONOSYL-, INNER SALT;1,2,4-Triazolo(4,3-b)pyridazinium, 7-(1,1-dimethylethyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-1-beta-D-glucopyranuronosyl-;1,2,4-Triazolo(4,3-b)pyridazinium, 7-(1,1-dimethylethyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-1-beta-D-glucopyranuronosyl-, inner salt;7-(1,1-DIMETHYLETHYL)-6-((1-ETHYL-1H-1,2,4-TRIAZOL-5-YL)METHOXY)-3-(2-FLUOROPHENYL)-1-.BETA.-D-GLUCOPYRANURONOSYL-1,2,4-TRIAZOLO(4,3-B)PYRIDAZINIUM;7-(1,1-Dimethylethyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-1-beta-D-glucopyranuronosyl-1,2,4-triazolo(4,3-b)pyridazinium
- Molecular Formula:C26H30FN7O7
- Molecular Weight:571.6
- CAS Registry Number:474319-48-7
- EINECS:
- Melting Point:
- Water Solubility:

Other Product
- 299166-81-7/Methyl 1-chloro-7-(phenylmethoxy)-4-(3,4,5-trimethoxyphenyl)-3-isoquinolinecarboxylate
- 117994-54-4/Phosphatidylcholine lyso 16:0
- 312760-13-7/(S)-2-(Phenylsulfonylamino)-3-[5-[2-(guanidinomethyl)phenyl]-2-thienylcarbonylamino]propionic acid
- 290352-02-2/Ethyl 2-[[3,5-dichloro-4-[3-[(cyclobutylmethyl)sulfonyl]-4-hydroxyphenoxy]phenyl]amino]-2-oxoacetate
- 435273-74-8/Indacaterol maleate
- 208641-01-4/(1-((5-Methyl-3-(2-methylsulfonylphenylsulfonyloxy)phenoxy)methyl)cyclopropyl-methoxy)guanidine hydrochloride
- 406913-72-2/5H-Indolo(2,3-a)pyrrolo(3,4-C)carbazole-5,7(6H)-dione, 12-(4-deoxy-4-fluoro-beta-D-glucopyranosyl)-3,9-difluoro-12,13-dihydro-
- 357608-27-6/DN6Ngb2QQ2
- 122666-95-9/Milbemycin A3
- 16502-99-1/Tricaprylyl citrate
- 390745-19-4/Romidepsin reduced
- 203855-56-5/4-Fluoro-gamma-oxo-alpha-(phenylmethyl)benzenebutanoic acid
- 340784-55-6/LY-368842 glycolate
- 193070-83-6/AR-C69457AA monohydrochloride
- 438576-82-0/W385HS2Jpv
- 216988-51-1/Unii-Z2QC9N9mqk
- 216988-52-2/O-1057 free base
- 628290-43-7/13-Deoxydoxorubicin
- 694491-71-9/4-Pyridinecarboxamide, 1-(8-(2,4-dichlorophenyl)-2-methyl-4-quinolinyl)-1,2,3,6-tetrahydro-, monobenzenesulfonate
- 474319-48-7/TPA023 metabolite M5
- 854374-08-6/Sucrose, 1-palmitate
- 264145-10-0/Methanesulfonamide, 1,1,1-trifluoro-N-(3-(((2R,3S,4R)-6-((5-fluoro-2-benzothiazolyl)methoxy)-3,4-dihydro-4-hydroxy-2-methyl-2H-1-benzopyran-3-yl)methyl)phenyl)-
- 185049-54-1/1,2,4-Benzenetricarboxylic acid, 5-((((2-ethoxyphenyl)methyl)((3-(4-methylphenoxy)phenyl)methyl)amino)carbonyl)-
- 112962-92-2/Isoclor
- 13102-49-3/Sucrose, 6-oleate
- 172174-30-0/ABT-299 cation
- 221332-74-7/Methanesulfonamide, N-(3-(((3S,4R)-6-((7-chloro-2-quinolinyl)methoxy)-3,4-dihydro-4-hydroxy-2,2-dimethyl-2H-1-benzopyran-3-yl)methyl)-4-methoxyphenyl)-1,1,1-trifluoro-
- 204251-45-6/(11R)-5,6-Dihydro-3,10-dibromo-8-chloro-11-[1-[1-oxo-2-[1-(carbamoylmethyl)-4-piperidinyl]ethyl]-4-piperidinyl]-11H-benzo[5,6]cyclohepta[1,2-b]pyridine
- 436099-66-0/(4S,5beta)-3-[[6-[2-[4-(Carbamoylmethyl)-1,4-diazoniabicyclo[2.2.2]octane-1-yl]ethyl]-2H-naphtho[1,8-cd]isothiazole 1,1-dioxide]-2-ylmethyl]-4alpha-methyl-6beta-[(R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hepta-2-ene-2-carboxylate
- 500170-31-0/Enalapril maleate and hydrochlorothiazide